Application Nr Approved Date Route Status External Links
ANDA201970 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1. Indications And Usage Rasagiline Mesylate Tablets Are Indicated For The Treatment Of Parkinson’s Disease (Pd). Rasagiline Mesylate Tablets, A Monoamine Oxidase (Mao)-B Inhibitor (Maoi), Is Indicated For The Treatment Of Parkinson’s Disease

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Rasagiline Mesylate RASAGILINE MESYLATE ZINC19875504

Comments